ACE2 and COVID-19: With regard to one of the key findings of the current study: association of PD and COVID-19 adverse outcomes, one possible explanation is related to the expression of angiotensin converting enzyme 2 (the well- known receptor for SARS-CoV-2) by the inspired periopathogenes.